Worldwide Healthcare Marketing & Communications Industry to 2026 – Growing Approach for Digitalization in Untapped Market Presents Opportunities – Yahoo Finance

Share Article

DUBLIN, Jan. 21, 2022 /PRNewswire/ — The "Healthcare Marketing & Communications Market Research Report by Type, by End-User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Healthcare Marketing & Communications Market size was estimated at USD 2,885.42 million in 2020, is expected to reach USD 3,443.95 million in 2021, and is projected to grow at a CAGR of 19.72% to reach USD 8,498.72 million by 2026.

Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Marketing & Communications Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare Marketing & Communications Market, including Advice Media, LLC, comHes, Experian PLC, Fishawack Health Group, Indegene Inc., Insignia Communications Private Limited, IQVIA Inc., LEVO Healthcare Consulting, LLC, McCann Worldgroup, MediaMedic Communications Pvt. Ltd., NexgenRx Inc., Open Health Communications LLP, Publicis Groupe, SCALE Healthcare, Spectrio, Inc., Syneos Health, Inc, Toppan Merrill LLC, and UDG Healthcare PLC.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Healthcare Marketing & Communications Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Marketing & Communications Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Marketing & Communications Market?
4. What is the competitive strategic window for opportunities in the Global Healthcare Marketing & Communications Market?
5. What are the technology trends and regulatory frameworks in the Global Healthcare Marketing & Communications Market?
6. What is the market share of the leading vendors in the Global Healthcare Marketing & Communications Market?
7. What modes and strategic moves are considered suitable for entering the Global Healthcare Marketing & Communications Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Demand for Enhanced Patient Experience through Increased Communication
5.1.1.2. Need for Effective Way to Communicate with the Stakeholders
5.1.1.3. Government Enforcement to Increase Patient Awareness & Education
5.1.2. Restraints
5.1.2.1. High Investment Requirement for Marketing Expertise
5.1.3. Opportunities
5.1.3.1. Growing Approach for Digitalization in Untapped Market
5.1.3.2. Rising partnership and Collaboration for Effective Marketing and Communication
5.1.4. Challenges
5.1.4.1. Mature Landscape and Transition Challenges from Traditional to Digital Marketing
5.2. Cumulative Impact of COVID-19

6. Healthcare Marketing & Communications Market, by Type
6.1. Introduction
6.2. Multi-Channel
6.3. Omnichannel

7. Healthcare Marketing & Communications Market, by End-User
7.1. Introduction
7.2. Healthcare Payer
7.3. Healthcare Provider
7.4. Patient

8. Americas Healthcare Marketing & Communications Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Healthcare Marketing & Communications Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Healthcare Marketing & Communications Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Advice Media, LLC
12.2. comHes
12.3. Experian PLC
12.4. Fishawack Health Group
12.5. Indegene Inc.
12.6. Insignia Communications Private Limited
12.7. IQVIA Inc.
12.8. LEVO Healthcare Consulting, LLC
12.9. McCann Worldgroup
12.10. MediaMedic Communications Pvt. Ltd.
12.11. NexgenRx Inc.
12.12. Open Health Communications LLP
12.13. Publicis Groupe
12.14. SCALE Healthcare
12.15. Spectrio, Inc.
12.16. Syneos Health, Inc
12.17. Toppan Merrill LLC
12.18. UDG Healthcare PLC

13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/vtd7b
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/worldwide-healthcare-marketing–communications-industry-to-2026—growing-approach-for-digitalization-in-untapped-market-presents-opportunities-301465646.html
SOURCE Research and Markets
SPECIAL TO BLACK ENTERPRISE: The dynamic duo of Real Estate Brokers Marvetta Bozeman and Ronnie DeVoe of DeVoe Real Estate offer readers tips on the 5 home improvement mistakes to avoid in seller's market.
The start-up battery maker for electric vehicles is exploring other options, and the market isn't impressed.
Shares of e-commerce technology-darling Shopify (NYSE: SHOP) were down 7.6% today as of 11:50 a.m. ET. The broader market indices had clawed back steep early losses, but no such luck for Shopify, as richly valued names continue to get punished. The drop is particularly confounding because Shopify just inked a deal with Chinese e-commerce giant JD.com (NASDAQ: JD).
Shares of Upstart Holdings (NASDAQ: UPST), a lender that uses artificial intelligence (AI) to make loan decisions, fell nearly 13.4% today after an analyst lowered his price target on the stock. Wedbush analyst David Chiaverini maintained his neutral rating on Upstart, but significantly lowered his price target from $160 to $110.
Hennion & Walsh Chief Investment Officer Kevin Mahn joins Yahoo Finance Live to discuss low trading sessions during market volatility, how investors should listen to their risk tolerance, what investment opportunities are making themselves known, and high interest rates.
Prominent market technician Ralph Acampora says the recent bout of market volatility has him uneasy and now he's forecasting a deeper drop in the market.
The surface of the S&P 500 makes markets look calm. But look down just one layer, and you see some serious pain.
(Bloomberg) — Shopify Inc. plunged by the most since March 2020 amid a report that the Canadian e-commerce company terminated contracts with several warehouse and fulfillment partners.Most Read from BloombergTech Leads Stocks to Worst Week Since March 2020: Markets WrapJeremy Grantham Doubles Down on Crash Call, Says Selloff Has StartedAmerican Airlines Sues The Points Guy Over Its Rewards Management AppCrypto Selloff Pushes Bitcoin to a Six-Month Low of $38,000Early Omicron Breakthroughs Show
The yield-sensitive Nasdaq Composite Index on Wednesday logs its first close in correction territory since March. Here's what history says happens next.
Arrival (NASDAQ: ARVL) is one of many fledgling electric vehicle (EV) companies that merged with a blank check company to raise funds and go public in 2021. The company has aspirations to supply zero-emission electric buses to municipalities and commercial vans to businesses. The sell-off in Arrival stock is continuing today, with shares down 12.4% as of 1:56 p.m. ET.
The U.S. is approaching the end of a 'superbubble,' potentially leading to the largest markdown of wealth in its history when pessimism returns to rule markets, according to legendary investor Jeremy Grantham.
In this article, we will discuss the 10 stocks that Izzy Englander has sold in Q3. You can skip our detailed analysis of his hedge fund and recent developments, and go directly to read Billionaire Izzy Englander is Selling These 5 Stocks. Israel Englander is one of the most prominent hedge fund managers of all […]
On Thursday, a flirtation with a respectable comeback a day after entering correction territory proved short-lived, with the Nasdaq Composite (COMP) notching another ugly reversal on Thursday. Thursday’s move appeared to be a head-scratcher for some participants as it seemed likely that the technology-laden Nasdaq Composite might finally finish higher, with momentum buoying the Dow Jones Industrial Average (DJIA) and the S&P 500 (SPX) benchmarks and bargain hunters swooping in. Read: The Nasdaq Composite just logged its 66th correction since 1971.
Yahoo Finance's Emily McCormick examines the market action ahead of the closing bell, taking a look at sector trading as trending stocks continue to dip.
(Bloomberg) — Selling has gotten intense enough in stocks that volatility indexes are pricing more turbulence in the here and now than in the future. The setup, known as an inverted VIX, is sometimes viewed as a positive for those hoping markets will calm.Most Read from BloombergTech Leads Stocks to Worst Week Since March 2020: Markets WrapJeremy Grantham Doubles Down on Crash Call, Says Selloff Has StartedAmerican Airlines Sues The Points Guy Over Its Rewards Management AppCrypto Selloff Pushe
On Wednesday, Jan. 26, Tesla (NASDAQ: TSLA) will report its Q4 earnings for fiscal year 2021 — so the fact that Tesla stock is falling today doesn't portend particularly well. As of 11 a.m. ET, Tesla stock is trading down 2.5% — about five times worse than the decline on the broader Nasdaq index. Why Tesla stock is down isn't immediately clear.
Rivian Automotive (NASDAQ: RIVN) isn't giving its shareholders any respite — the electric vehicle (EV) stock was down by 22.6% for the week as of 10:30 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. At this point, Rivian has declined by a whopping 41% year to date. Given that the market had already been warned, investors shouldn't have been surprised when Rivian announced the actual numbers.
The narrative around Block (SQ) right now is one that is not unique in the fintech space. A changing macro environment, concerns over decelerating growth, and difficult comps after the pandemic-driven growth are all reasons why sentiment has soured on this name. But sentiment is not set in stone, at least if there’s enough evidence to support the notion the various concerns can be addressed. Assessing this previous high-flyer’s prospects, Deutsche Bank’s Bryan Keane thinks there are enough reaso
Ahead of Apple's results, Wells Fargo raises its estimates for quarterly revenue and profits, and boosts the stock price target.
Russia may be considering a ban on cryptocurrencies, which might be negatively impacting the price of the world's largest cryptocurrency by market capitalization: Bitcoin. For its part, Bitcoin is down about 11% over the past 24 hours, as of 2:45 p.m. ET.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness